Enveric Biosciences, Inc. Logo

Enveric Biosciences, Inc.

Develops novel small-molecule therapeutics for neuropsychiatric disorders.

ENVB | US

Overview

Corporate Details

ISIN(s):
US02362F3029 (+1 more)
LEI:
Country:
United States of America
Address:
245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE

Description

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 18:10
8-K
English 393.1 KB
2025-12-11 18:41
8-K
English 72.0 KB
2025-12-10 21:47 English 8.6 KB
2025-12-10 21:47 English 8.8 KB
2025-12-10 02:08
424B3
English 72.2 KB
2025-12-09 06:15 English 5.2 KB
2025-12-06 01:06 English 8.8 KB
2025-12-05 23:40 English 8.9 KB
2025-12-05 23:18
S-3/A
English 102.2 KB
2025-11-14 22:31
10-Q
English 912.7 KB
2025-11-14 22:05
8-K
English 64.2 KB
2025-11-14 22:05
8-K
English 96.7 KB
2025-11-13 21:42 English 9.6 KB
2025-10-27 21:30
DEF 14A
English 1.4 MB
2025-10-23 22:30
8-K
English 112.7 KB

Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enveric Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.